產(chǎn)品名稱 |
Caki-2 |
商品貨號 |
B164111 |
Organism |
Homo sapiens, human |
Tissue |
kidney |
Product Format |
frozen |
Morphology |
epithelial |
Culture Properties |
adherent |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease |
clear cell carcinoma |
Age |
69 years |
Gender |
male |
Ethnicity |
Caucasian |
Storage Conditions |
liquid nitrogen vapor phase |
Karyotype |
(P8) hypopentaploid to hypohexaploid (+A2, +A3, +B, +C, +D, +F, +G, -A) with abnormalities including dicentrics, acrocentric fragments, minutes, breaks, and large subtelocentric markers |
Images |
|
Derivation |
According to the originator, Caki-2 was established from a primary clear cell carcinoma of the kidney. This is another line isolated from a primary renal carcinoma by J. Fogh as indicated in the description for ATCC HTB-46. |
Clinical Data |
69 years Caucasian male |
Antigen Expression |
Antigen expression: Blood Type A; Rh- |
Tumorigenic |
Yes |
Effects |
Yes, in nude mice; forms clear cell carcinoma |
Comments |
Recent evaluation (K. Pulkkanen and J. Parkinen, personal communication) of nude mouse tumors formed by this line in orthotopic and s.c. implantations were consistent with cystic papillary renal cell carcinoma according to the criteria of Kovacs et al.
Ultrastructural features reported include microvilli and microfilaments with few mitochondria, lysosomes or lipid droplets.
Frequent multilamellar bodies were observed, but no virus particles were seen. |
Complete Growth Medium |
The base medium for this cell line is ATCC-formulated McCoy's 5a Medium Modified, Catalog No. 30-2007. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
Subculturing |
Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 mL of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37°C) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended
Medium Renewal: 2 to 3 times per week |
Cryopreservation |
Culture medium, 95%; DMSO, 5% |
STR Profile |
Amelogenin: X,Y CSF1PO: 10,12 D13S317: 10 D16S539: 9,13 D5S818: 11 D7S820: 12 THO1: 6 TPOX: 9,11 vWA: 16,17 |
Isoenzymes |
AK-1, 1 ES-D, 1 G6PD, B GLO-I, 1-2 Me-2, 1 PGM1, 1 PGM3, 1 |
Name of Depositor |
J Fogh |
Deposited As |
Homo sapiens |
References |
Fogh J. Human tumor cells in vitro. New York: Plenum Press; 1975.
Fogh J, et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. 58: 209-214, 1977. PubMed: 833871
Goodfellow M, et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl. Cancer Inst. 59: 221-226, 1977. PubMed: 77210034
Fogh J. Cultivation, characterization, and identification of human tumor cells with emphasis on kidney, testis, and bladder tumors. Natl. Cancer Inst. Monogr. 49: 5-9, 1978. PubMed: 571047
Kovacs G, et al. The Heidelberg classification of renal cell tumors. J. Pathol. 183: 131-133, 1997. PubMed: 9390023
|